KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹124 Cr | ₹141 Cr | ₹115 Cr | ₹110 Cr | ₹114 Cr |
What is the latest Total Liabilities ratio of KERALA AYURVEDA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹141 Cr |
| Mar2023 | ₹115 Cr |
| Mar2022 | ₹110 Cr |
| Mar2021 | ₹114 Cr |
How is Total Liabilities of KERALA AYURVEDA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹124 Cr | -11.88 | |
| Mar2024 | ₹141 Cr | 22.14 | |
| Mar2023 | ₹115 Cr | 4.68 | |
| Mar2022 | ₹110 Cr | -3.36 | |
| Mar2021 | ₹114 Cr | - | |
Compare Total Liabilities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹374.1 Cr | -1.9% | 1.3% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -1.9% |
1.3% |
-24.7% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses